Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Makrides

Showing results (201-210 of 238) with videos related to

Pageof 24
Sort By:
Pediatrics|September 28, 2011
Infant growth before and after term: effects on neurodevelopment in preterm infantsMandy B Belfort, Sheryl L Rifas-Shiman, Thomas Sullivan, et al.
JAMA Network Open|July 11, 2022
Associations of Maternal Milk Feeding With Neurodevelopmental Outcomes at 7 Years of Age in Former Preterm InfantsMandy B Belfort, Emma Knight, Shikha Chandarana, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 1, 2026
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current PracticeHossein Haji Ali Afzali, Ecushla Linedale, Craig Martin, et al.
The British Journal of Nutrition|March 30, 2011
Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trialCarmel T Collins, Maria Makrides, Robert A Gibson, et al.
The American Journal of Clinical Nutrition|April 3, 2025
High-dose docosahexaenoic acid for bronchopulmonary dysplasia severity in very preterm infants: a collaborative individual participant data meta-analysisIsabelle Marc, Pascal M Lavoie, Thomas R Sullivan, et al.
Allergy|October 11, 2020
Longitudinal egg-specific regulatory T- and B-cell development: Insights from primary prevention clinical trials examining the timing of egg introductionCatherine L Lai, Dianne E Campbell, Debra J Palmer, et al.
Frontiers in Pediatrics|May 19, 2023
Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trialKaren P Best, Lisa N Yelland, Carmel T Collins, et al.
JAMA|January 15, 2009
Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trialMaria Makrides, Robert A Gibson, Andrew J McPhee, et al.
Clinical Epigenetics|November 9, 2016
Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trialSusan J van Dijk, Jing Zhou, Timothy J Peters, et al.
The Medical Journal of Australia|November 11, 2025
The early implementation phase of the Omega-3 Test-and-Treat Program for reducing the risk of preterm birth, South Australia, 2021-22: an implementation evaluation studyKaren P Best, Celine Northcott, Lucy A Simmonds, et al.
Pageof 24

Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
Pediatrics|September 28, 2011
Infant growth before and after term: effects on neurodevelopment in preterm infantsMandy B Belfort, Sheryl L Rifas-Shiman, Thomas Sullivan, et al.
JAMA Network Open|July 11, 2022
Associations of Maternal Milk Feeding With Neurodevelopmental Outcomes at 7 Years of Age in Former Preterm InfantsMandy B Belfort, Emma Knight, Shikha Chandarana, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 1, 2026
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current PracticeHossein Haji Ali Afzali, Ecushla Linedale, Craig Martin, et al.
The British Journal of Nutrition|March 30, 2011
Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trialCarmel T Collins, Maria Makrides, Robert A Gibson, et al.
The American Journal of Clinical Nutrition|April 3, 2025
High-dose docosahexaenoic acid for bronchopulmonary dysplasia severity in very preterm infants: a collaborative individual participant data meta-analysisIsabelle Marc, Pascal M Lavoie, Thomas R Sullivan, et al.
Allergy|October 11, 2020
Longitudinal egg-specific regulatory T- and B-cell development: Insights from primary prevention clinical trials examining the timing of egg introductionCatherine L Lai, Dianne E Campbell, Debra J Palmer, et al.
Frontiers in Pediatrics|May 19, 2023
Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trialKaren P Best, Lisa N Yelland, Carmel T Collins, et al.
JAMA|January 15, 2009
Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trialMaria Makrides, Robert A Gibson, Andrew J McPhee, et al.
Clinical Epigenetics|November 9, 2016
Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trialSusan J van Dijk, Jing Zhou, Timothy J Peters, et al.
The Medical Journal of Australia|November 11, 2025
The early implementation phase of the Omega-3 Test-and-Treat Program for reducing the risk of preterm birth, South Australia, 2021-22: an implementation evaluation studyKaren P Best, Celine Northcott, Lucy A Simmonds, et al.
Pageof 24